Is Boeing's New 777-9 Plane a Reason to Buy the Stock?

Boeing shares rose 7.6% for the week ended May 11 after the first Lufthansa 777-9 completed a successful test flight with a full interior on May 7. The result improves sentiment around certification and possible deliveries later this year, easing fears of a delay into 2027. Additional upside could come from a potential China order for 500 737 MAX jets, though that remains speculative.

Analysis

BA is acting like a call option on execution rather than on fundamentals alone: the market is rewarding any evidence that certification risk is receding because the next leg of upside depends on de-risking the production/entry-into-service path, not on a full demand re-rate. The immediate winner is the supply chain tied to widebody ramp, but the second-order benefit is to Boeing’s own pricing power — every credible milestone lowers the discount rate investors apply to future cash flows and narrows the gap between order book value and realizable value.

The more interesting angle is timing. The stock can continue to squeeze over days to weeks if the market starts treating the 777-9 as a template for broader program normalization, but the real monetization window is months, when deliveries and certification steps either translate into cash or expose another slip. If Boeing hits one more clean milestone, short-covering could persist; if it misses, the move likely reverses quickly because the bull case is still fragile and headline-dependent.

A China trip is a potential catalyst, but the market may be overestimating how quickly any commercial signal there converts into firm backlog. Large China orders are more about geopolitical signaling and fleet replacement logistics than instant revenue, so even a favorable outcome may function more as sentiment support than as a near-term earnings catalyst. The bigger incremental benefit would be to suppliers and engine/parts providers with leverage to widebody and MAX production rates, which should outperform if Boeing’s cadence normalizes.

The contrarian view is that the recent rally is partly a relief move into a structurally challenged name, and relief rallies in aerospace often outrun the actual improvement in free cash flow. If delivery schedules slip or certification scrutiny re-intensifies, the downside can be abrupt because positioning is likely crowded after a sharp bounce. In other words: the stock may be under-earning the right to sustain a re-rating, but over-earning the right to be chased here without a tighter catalyst map.

Key Decisions for Investors

• Tactically long BA for 2-6 weeks into the next certification/delivery headline, but size it as a momentum trade rather than a fundamental core holding; stop if the stock gives back the post-test-flight breakout low.
• Prefer a pair trade: long BA / short a higher-quality industrial or aerospace proxy with less headline beta, to isolate de-risking upside while capping market risk if the broad tape weakens.
• Use upside structures in BA instead of outright stock: buy 1-3 month calls or call spreads to express a near-term squeeze thesis with defined downside, since the move is still event-driven and can reverse on one negative headline.
• Watch suppliers with widest production leverage to Boeing cadence and look for a lagging-long opportunity if BA confirms further progress; the cleanest follow-through should show up first in the supply chain, not the parent.